SS-31's proposed mechanism is defined by where it goes and what it binds: the inner mitochondrial membrane and its signature phospholipid, cardiolipin. Unlike peptides that act at cell-surface receptors, SS-31 works inside the cell at a specific organelle, which shapes every aspect of how it is studied.
Mitochondrial targeting
The peptide's aromatic-cationic design drives selective accumulation at the inner mitochondrial membrane, which carries a strong negative electrochemical potential. The net-positive peptide is drawn to this environment while its aromatic residues anchor it, allowing it to concentrate there far more than a typical small peptide would.
Cardiolipin interaction
Once localized, SS-31 is proposed to associate with cardiolipin, a phospholipid unique to the inner mitochondrial membrane. Cardiolipin helps organize and stabilize the electron-transport-chain complexes and cristae architecture, so a peptide that binds it is studied for effects on mitochondrial-membrane integrity and structural organization.
Bioenergetic readouts
Because cardiolipin supports efficient electron transport, SS-31 is examined for its influence on bioenergetic efficiency — how well mitochondria maintain membrane potential and produce ATP under stress in model systems. These endpoints are central to how the peptide is characterized.
Oxidative-stress readouts
In model systems SS-31 is also examined for its influence on reactive-oxygen-species handling, linking it to the broader oxidative-stress and energy-metabolism research that also involves NAD+ pathways. Related mitochondrial tools such as MOTS-c engage the organelle through different routes.
Interpreting results
In-vitro concentrations are set by assay design, not human dosing, and mitochondrial readouts depend heavily on the model system and stress conditions used. Foundational context is in the SS-31 overview.
Avoiding an oversimplified antioxidant label
Reduced oxidative-stress markers are downstream observations, not proof that SS-31 acts as a freely circulating radical scavenger. Its localization and cardiolipin interaction provide a more specific mechanistic framework: changes in membrane organization or electron-transfer efficiency can alter where reactive oxygen species arise and how mitochondria respond to stress. Experiments should therefore measure target engagement or mitochondrial localization alongside redox endpoints when possible. Comparators that lack the aromatic-cationic sequence, measurements in isolated membranes, and time-resolved bioenergetic assays help distinguish direct chemical quenching from secondary changes caused by altered mitochondrial function. Cardiolipin oxidation, cristae morphology, and respiratory-complex organization are related but separate variables, so experiments should avoid treating any one measurement as a complete account of the mechanism.
Product page: SS-31 research vials.
Research Use Only. Supplied strictly for laboratory research and development — not for human or veterinary use, consumption, or any therapeutic or diagnostic purpose. This article is research education, not usage guidance.